OGSIVEO Presentation – June 20th
Please join us for a presentation on: OGSIVEOTM (nirogacestat), the first and only FDA-approved therapy for adult patients with progressing desmoid tumors who require systemic treatment
Program details:
Thursday, June 20, 2024
6:00 PM Pacific Daylight Time Presentation
Fogo de Chao
377 Santana Row #1090
San Jose , CA 95128
Presented by:
Noah Federman, MD
Medical Director: Clinical Translational Research Center;
Director: Pediatric Bone and Soft Tissue Program
UCLA Health
Los Angeles, CA
Use the link below to register for this event
https://www.swtxspeakerprograms.com/attendee
If you have questions about the event, you can contact your SpringWorks Therapeutics representative, Mackenzie Burke at mackenzie.burke@springworkstx.com or +1 925-785-4672. If you have registration questions, you can email springworks@bcdme.com